Susmed (TSE:4263) Total Liabilities: 円114.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4263 Susmed Inc TSE:4263
55 GF Score
Price 円422.00
GF Value 円903.11
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Susmed Total Liabilities?

Susmed TSE:4263 -0.94% 55 Total Liabilities is 円114.4 Mil as of Mar. 2026. GuruFocus rates TSE:4263 with a GF Score™ of 55/100 and a GF Value™ of 円903.11 (Possible Value Trap). The stock has 4 warning signs investors should review.

Susmed's Total Liabilities for the quarter that ended in Mar. 2026 was 円114.4 Mil.

Susmed's quarterly Total Liabilities declined from Sep. 2025 (円121.25 Mil) to Dec. 2025 (円117.26 Mil) and declined from Dec. 2025 (円117.26 Mil) to Mar. 2026 (円114.37 Mil).

Susmed's annual Total Liabilities declined from Jun. 2024 (円327.79 Mil) to Jun. 2025 (円132.33 Mil) but then increased from Jun. 2025 (円132.33 Mil) to Jun. 2026 (円147.94 Mil).

Susmed Total Liabilities Historical Data

* Premium members only.

The historical data trend for Susmed's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed Total Liabilities Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Total Liabilities
Get a 7-Day Free Trial 93.34 230.33 327.79 132.33 147.94

Susmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.33 121.25 117.26 114.37 147.94
TSE:4263
55GF Score
Susmed Inc TSE:4263
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Susmed Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Susmed's Total Liabilities for the fiscal year that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=147.943+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=147.9

Total Liabilities=Total Assets (A: Jun. 2026 )-Total Equity (A: Jun. 2026 )
=4218.107-4070.163
=147.9

Susmed's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=114.372+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=114.4

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=4223.251-4108.878
=114.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円114.4 Mil mean?
Susmed (TSE:4263) has a Total Liabilities of 円114.4 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Susmed and its competitors.
Is Susmed's Total Liabilities too high?
Susmed's current Total Liabilities is 円114.4 Mil. Overall, Susmed has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Susmed's Total Liabilities compare to VEEV and BTSG?
Susmed's Total Liabilities of 円114.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Susmed and its competitors. Susmed's current Total Liabilities is 円114.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Possible Value Trap. The stock's GF Value™ is 円903.11, compared to a current price of 円422.00 — trading 53.3% below its estimated fair value. The current Total Liabilities is 円114.4 Mil. Susmed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Susmed (TSE:4263), the current Total Liabilities is 円114.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Susmed (TSE:4263) Overvalued in 2026?

Based on GuruFocus' analysis, Susmed stock appears to be undervalued. The current stock price of 円422.00 is trading 53.3% below its estimated GF Value™ of 円903.11. GuruFocus considers Susmed to be Possible Value Trap.

Key valuation signals for TSE:4263:

  • Total Liabilities: 円114.4 Mil
  • GF Value™: 円903.11 vs. price of 円422.00 (53.3% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Susmed Business Description

Address 3-7-2 Nihonbashi Honcho, 10th Floor, MFPR Nihonbashi Honcho Building, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
55GF Score

Get the complete analysis for TSE:4263

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円422.00
Price
円903.11
GF Value